Why the study?
Does direct injection of parvalbumin cDNA improve skeletal muscle relaxation speed in rat soleus muscles?
Does direct injection of parvalbumin cDNA improve skeletal muscle relaxation speed in rat soleus muscles?
Direct gene transfer of parvalbumin cDNA into slow-contracting rat soleus muscle significantly shortens half-relaxation time, demonstrating its physiological role as a relaxing factor.
Answers are grounded in this paper and cite their sources.
Shortens relaxation time in rat soleus; leaves open whether parvalbumin gene transfer has therapeutic value in human myopathies.
Parvalbumin (PV) is a high affinity Ca(2+)-binding protein found at high concentration in fast-contracting/relaxing skeletal muscle fibers of vertebrates. It has been proposed that PV acts in the process of muscle relaxation by facilitating Ca2+ transport from the myofibrils to the sarcoplasmic reticulum. However, on the basis of metal-binding kinetics of PV in vitro, this hypothesis has been challenged. To investigate the function of PV in skeletal muscle fibers, direct gene transfer was applied in normal and regenerating rat soleus muscles which do not synthesize detectable amounts of PV. Two weeks after in vivo transfection with PV cDNA, considerable levels of PV mRNA and protein were detected in normal muscle, and even higher amounts were detected in regenerating muscle. Twitch half-relaxation time was significantly shortened in a dose-dependent way in transfected muscles, while contraction time remained unaltered. The observed shortening of half-relaxation time is due to PV and its ability to bind Ca2+, because a mutant protein lacking Ca(2+)-binding capacity did not promote any change in physiology. These results directly demonstrate the physiological function of PV as a relaxing factor in mammalian skeletal muscle.
No takes yet. Share an insight, caveat, or question.
Müntener et al. (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: